Initial clinical experience with a biofragmentable ring for sutureless bowel anastomosis

Thomas G. Jr. Hardy,P. S. Aguilar,W. R. Stewart,A. R. Katz,J. Maney,J. T. Costanzo,W. Pace

DOI: https://doi.org/10.1007/BF02556926

Diseases of the Colon & Rectum

Abstract:

What problem does this paper attempt to address?

Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs

Jiangkang Xu,Abdur Rauf Khan,Manfei Fu,Rujuan Wang,Jianbo Ji,Guangxi Zhai

DOI: https://doi.org/10.1016/j.jconrel.2019.07.020

2019-09-10

Abstract:The selective infiltration of cell membranes and tissue barriers often blocks the entry of most active molecules. This natural defense mechanism prevents the invasion of exogenous substances and limits the therapeutic value of most available molecules. Therefore, it is particularly important to find appropriate ways of membrane translocation and therapeutic agent delivery to its target site. Cell penetrating peptides (CPPs) are a group of short peptides harnessed in this condition, possessing a significant capacity for membrane transduction and could be exploited to transfer various biologically active cargoes into the cells. Since their discovery, CPPs have been employed for delivery of a wide variety of therapeutic molecules to treat various disorders including cranial nerve involvement, ocular inflammation, myocardial ischemia, dermatosis and cancer. The promising results of CPPs-derived therapeutics in various tumor models demonstrated a potential and worthwhile scope of CPPs in chemotherapy. This review describes the detailed description of CPPs and CPPs-assisted molecular delivery against various tissues and organs disorders. An emphasis is focused on summarizing the novel insights and achievements of CPPs in surmounting the natural membrane barriers during the last 5 years.
Penetrating peptides: Applications in drug delivery

Jiangkang Xu,Fenghua Wang,Lei Ye,Rui Wang,Lixia Zhao,Xiaoye Yang,Jianbo Ji,Anchang Liu,Guangxi Zhai

DOI: https://doi.org/10.1016/j.jddst.2023.104475

IF: 5

2023-06-01

Journal of Drug Delivery Science and Technology

Abstract:Cell-penetrating peptides (CPPs) have gained prominence in intracellular drug delivery due to their extremely low toxicity and rapid cell internalization property. They present a powerful strategy for overcoming the plasma membrane barrier and improving the cellular uptake of multiple macromolecular drugs (siRNA, DNA, protein, and drug carriers). Nevertheless, the disadvantages of degradation by hydrolytic enzymes and lack of target selectivity have limited their applications. The development of artificial CPPs has provided an optimized sequence and spatial structure to overcome the mentioned challenges while retaining their biological activities. Owing to the diversity of CPPs, generalization of their cell-penetration mechanism is difficult. However, factors that affect CPP penetration, such as charge, pH, concentration, and temperature, are increasingly being studied. Delivery using CPPs, represented by cationic peptides, involves sequential penetration of the entire thickness of tissues to achieve cell targeting and drug release. Novel CPPs and intelligent-responsive CPP-mediated drug delivery systems have been developed simultaneously to realize the purposes of selective penetration and targeted delivery. This review highlights the application, progress, mechanism and prospect of CPPs in the process of penetrating the barrier, and discusses the most up-to-date advances of CPPs in intracellular drug delivery for targeted therapy.

pharmacology & pharmacy
A questionnaire survey of sleep and night-time behaviour in a community-based sample of adults with intellectual disability.

J. Brylewski,L. Wiggs

DOI: https://doi.org/10.1046/J.1365-2788.1998.00111.X

IF: 3.646

1998-04-01

Journal of Intellectual Disability Research

Abstract:Two hundred and five people with intellectual disability, aged 18 years or over, and living in health- or social-services-managed community housing, completed sleep and behaviour questionnaires. An 85.7% return rate was achieved. Settling problems were present in 26.8% and night waking in 55.6% of the subjects. Parasomnias were present in 14% of subjects and 15% of the sample showed some features associated with sleep-related breathing problems. Factors associated with sleep-related problems included gender, aetiology of intellectual disability, epilepsy, treatment with antiepileptic medication, evening caffeine consumption, nocturnal urinary incontinence and ability to communicate. Significant sleep-related problems were demonstrated in this population; some of these problems might be avoided by simple measures.
Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.

Ting Kang,Xiaoling Gao,Jun Chen

DOI: https://doi.org/10.2174/1389201015666140617094952

2014-01-01

Current Pharmaceutical Biotechnology

Abstract:The existence of blood-brain barrier (BBB) represents the most formidable challenge for drug delivery to the central nervous system (CNS). Modern breakthrough in biology offers multiple choices for overcoming this barrier but yields modest outcomes for clinical application due to various problems such as safety concerns, insufficient delivery efficiency and poor penetration. Cell penetrating peptides (CPPs) possessing powerful transmembrane capacity have been shown to be effective transport vectors for bioactive molecules and an attractive alternative to traditional active targeting approaches. However, the non-specificity of CPPs has hindered them from targeting a desired site of action. Promisingly, design of novel CPP-mediated nanoparticulate delivery systems with specific targeting property may extricate CPPs from the dilemma. In this review, both the traditional and novel applications of CPPs-based strategies for CNS drug delivery will be discussed.
Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

Huifeng Zhang,Yanfei Zhang,Chuang Zhang,Huan Yu,Yinghui Ma,Zhengqiang Li,Nianqiu Shi

DOI: https://doi.org/10.3390/pharmaceutics15082093

IF: 6.525

2023-08-08

Pharmaceutics

Abstract:Peptides and proteins, two important classes of biomacromolecules, play important roles in the biopharmaceuticals field. As compared with traditional drugs based on small molecules, peptide- and protein-based drugs offer several advantages, although most cannot traverse the cell membrane, a natural barrier that prevents biomacromolecules from directly entering cells. However, drug delivery via cell-penetrating peptides (CPPs) is increasingly replacing traditional approaches that mediate biomacromolecular cellular uptake, due to CPPs' superior safety and efficiency as drug delivery vehicles. In this review, we describe the discovery of CPPs, recent developments in CPP design, and recent advances in CPP applications for enhanced cellular delivery of peptide- and protein-based drugs. First, we discuss the discovery of natural CPPs in snake, bee, and spider venom. Second, we describe several synthetic types of CPPs, such as cyclic CPPs, glycosylated CPPs, and D-form CPPs. Finally, we summarize and discuss cell membrane permeability characteristics and therapeutic applications of different CPPs when used as vehicles to deliver peptides and proteins to cells, as assessed using various preclinical disease models. Ultimately, this review provides an overview of recent advances in CPP development with relevance to applications related to the therapeutic delivery of biomacromolecular drugs to alleviate diverse diseases.

pharmacology & pharmacy
Lifestyle Modification in Cervical Cancer Survivors: An Ongoing Need

M. Schlumbrecht,Charlotte C. Sun,Marilyn Huang,F. Zandstra,D. Bodurka

DOI: https://doi.org/10.1097/IGC.0000000000000081

2014-03-01

International Journal of Gynecologic Cancer

Abstract:Objective With the introduction of multimodality therapy for cervical cancer, many women will be long-term survivors in need of comprehensive surveillance care. Our goals were to evaluate patterns of obesity and smoking in a cohort of cervical cancer survivors and to assess the potential influence of these comorbidities on subsequent follow-up. Methods We reviewed the records of patients treated for invasive cervical cancer at our institution from 2000 to 2003 who had no evidence of disease for 3 or more years. Demographic and clinical data were collected, including smoking history and anthropometric measurements. Body mass index (BMI) was categorized according to World Health Organization criteria. Logistic regression and Wilcoxon rank sum analyses were performed. Results Two hundred ninety-eight women had complete follow-up data at 3 years. The median age at diagnosis was 43.5 years (range, 17.6–87.1 years). At diagnosis, 31.9% had a normal BMI, 28.2% were overweight, and 34.6% were obese compared with 31.7%, 21.1%, and 30.2% at 3 years, respectively. Of the 51 women whose BMI categorization changed, 33 (64.7%) had weight gain, and 18 (35.3%) had weight loss. By paired analyses, increase in BMI was significant over the 3-year interval (P < 0.001). Seventy patients actively smoked at diagnosis. Compared with nonsmokers, current smokers had a greater odds of referral to the pain service (odds ratio [OR], 6.56; confidence interval [CI], 6.26–16.43; P < 0.001), physical therapy (OR, 4.74; CI, 1.29–17.36; P = 0.02), and gastroenterology (OR, 2.25; CI, 1.14–4.24; P = 0.02). Conclusions Obesity and smoking are significant comorbidities that may complicate care in cervical cancer survivors. Interventions aimed at modifying these risk factors should be routinely undertaken in this population.
AN APPARATUS FOR MACROSCOPIC CATAPHORESIS EXPERIMENTS

J. Northrop,G. E. Cullen

DOI: https://doi.org/10.1085/JGP.4.6.635

1922-07-20

The Journal of General Physiology

Abstract:The form of apparatus 1 shown in Fig. 1 has been found very convenient for the determination of the migration of fine suspensions in the electric field. Its essential difference from the usual cataphoresis apparatus is that the whole is inverted so that the central portion, which contains the suspension which is to be studied, is above the heavier electrode solutions and may be left open. This increases both the convenience and accuracy of method since (1) a greater latitude in concentration of solution is allowed, (2) the boundaries may be adjusted more exactly, and (3) the solution may be renewed without disturbing the electrode solution. The zinc electrodes are put in place with rubber stoppers, the tube is damped in a vertical position, and the apparatus is filled with saturated zinc sulfate. The three-way stop-cocks are then dosed and the zinc sulfate in the upper part of the cell is washed out through the "tail holes." The tubes above the stop-cocks are now filled with 0.1 x~ sucrose solution containing the same concentration of electrolyte or other substance as is to be used with the suspension. The sugar solution is then allowed to run out until the level reaches the small tube connecting the funnel and the U-tube. The suspension is then added and the level adjusted carefully by means of the stop-cocks so that the line of demarcation is opposite one of the graduations on the side arms. The upper stop-cock is then dosed and the lower ones are opened so as to connect the zinc sulfate with the sugar solutions. The current is applied and the distance traversed by the boundary determined after a convenient interval.
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application

Jing Xie,Ye Bi,Huan Zhang,Shiyan Dong,Lesheng Teng,Robert J. Lee,Zhaogang Yang

DOI: https://doi.org/10.3389/fphar.2020.00697

IF: 5.6

2020-05-20

Frontiers in Pharmacology

Abstract:Cell-penetrating peptides (CPPs) are short peptides (fewer than 30 amino acids) that have been predominantly used in basic and preclinical research during the last 30 years. Since they are not only capable of translocating themselves into cells but also facilitate drug or CPP/cargo complexes to translocate across the plasma membrane, they have potential applications in the disease diagnosis and therapy, including cancer, inflammation, central nervous system disorders, otologic and ocular disorders, and diabetes. However, no CPPs or CPP/cargo complexes have been approved by the US Food and Drug Administration (FDA). Many issues should be addressed before translating CPPs into clinics. In this review, we summarize recent developments and innovations in preclinical studies and clinical trials based on using CPP for improved delivery, which have revealed that CPPs or CPP-based delivery systems present outstanding diagnostic therapeutic delivery potential.

pharmacology & pharmacy
Cell penetrating peptides: Highlighting points in cancer therapy

Akmal M. Asrorov,Huiyuan Wang,Meng Zhang,Yonghui Wang,Yang He,Mirkomil Sharipov,Abulimiti Yili,Yongzhuo Huang

DOI: https://doi.org/10.1002/ddr.22076

2023-05-19

Drug Development Research

Abstract:Cell‐penetrating peptides (CPPs), first identified in HIV a few decades ago, deserved great attention in the last two decades; especially to support the penetration of anticancer drug means. In the drug delivery discipline, they have been involved in various approaches from mixing with hydrophobic drugs to the use of genetically conjugated proteins. The early classification as cationic and amphipathic CPPs has been extended to a few more classes such as hydrophobic and cyclic CPPs so far. Developing potential sequences utilized almost all methods of modern science: choosing high‐efficiency peptides from natural protein sequences, sequence‐based comparison, amino acid substitution, obtaining chemical and/or genetic conjugations, in silico approaches, in vitro analysis, animal experiments, etc. The bottleneck effect in this discipline reveals the complications that modern science faces in drug delivery research. Most CPP‐based drug delivery systems (DDSs) efficiently inhibited tumor volume and weight in mice, but only in rare cases reduced their levels and continued further processes. The integration of chemical synthesis into the development of CPPs made a significant contribution and even reached the clinical stage as a diagnostic tool. But constrained efforts still face serious problems in overcoming biobarriers to reach further achievements. In this work, we reviewed the roles of CPPs in anticancer drug delivery, focusing on their amino acid composition and sequences. As the most suitable point, we relied on significant changes in tumor volume in mice resulting from CPPs. We provide a review of individual CPPs and/or their derivatives in a separate subsection.

pharmacology & pharmacy,chemistry, medicinal
Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review

Ying Zhang,Pan Guo,Zhe Ma,Peng Lu,Dereje Kebebe,Zhidong Liu

DOI: https://doi.org/10.1186/s12951-021-01002-3

IF: 10.2

2021-08-23

Journal of Nanobiotechnology

Abstract:Abstract Although nanomedicine have greatly developed and human life span has been extended, we have witnessed the soared incidence of central nervous system (CNS) diseases including neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease), ischemic stroke, and brain tumors, which have severely damaged the quality of life and greatly increased the economic and social burdens. Moreover, partial small molecule drugs and almost all large molecule drugs (such as recombinant protein, therapeutic antibody, and nucleic acid) cannot cross the blood–brain barrier. Therefore, it is especially important to develop a drug delivery system that can effectively deliver therapeutic drugs to the central nervous system for the treatment of central nervous system diseases. Cell penetrating peptides (CPPs) provide a potential strategy for the transport of macromolecules through the blood–brain barrier. This study analyzed and summarized the progress of CPPs in CNS diseases from three aspects: CPPs, the conjugates of CPPs and drug, and CPPs modified nanoparticles to provide scientific basis for the application of CPPs for CNS diseases.

biotechnology & applied microbiology,nanoscience & nanotechnology
Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics

Kaido Kurrikoff,Birgit Vunk,Ülo Langel

DOI: https://doi.org/10.1080/14712598.2021.1823368

2020-09-23

Expert Opinion on Biological Therapy

Abstract:In this review, recent developments and applications with cell-penetrating peptides (CPP) are discussed. CPPs are widely used tools for the delivery of various macromolecular therapeutics, such as proteins and nucleic acids.The current review focuses on recent important advances and reports that demonstrate high clinical and translational potential. Most important clinical developments have occurred with the CPP-drug conjugate approaches that target various protein–protein interactions, and these have been highlighted subsequently. Most of the applications are targeting cancer, but recently, noteworthy advances have taken place in the field of antisense oligonucleotides and muscular dystrophies, lung targeting, and trans-BBB targeting.Successful applications and clinical development with the drug conjugate approaches are discussed. On the other hand, the reasons of why the nanoparticle approaches are not as far in development are analyzed.

medicine, research & experimental,biotechnology & applied microbiology
Cell-Penetrating Peptides: A Powerful Tool for Targeted Drug Delivery

Dushyant D Kotadiya,Piyushkumar Patel,Hitesh D Patel

DOI: https://doi.org/10.2174/1567201820666230407092924

Abstract:The cellular membrane hinders the effective delivery of therapeutics to targeted sites. Cellpenetrating peptide (CPP) is one of the best options for rapidly internalizing across the cellular membrane. CPPs have recently attracted lots of attention because of their excellent transduction efficiency and low cytotoxicity. The CPP-cargo complex is an effective and efficient method of delivering several chemotherapeutic agents used to treat various diseases. Additionally, CPP has become another strategy to overcome some of the current therapeutic agents' limitations. However, no CPP complex is approved by the US FDA because of its limitations and issues. In this review, we mainly discuss the cellpenetrating peptide as the delivery vehicle, the cellular uptake mechanism of CPPs, their design, and some strategies to synthesize the CPP complex via some linkers such as disulfide bond, oxime, etc. Here, we also discuss the recent status of CPPs in the market.
Case report: cystic gynecomastia in a male treated with clomiphene citrate.

J. Check,M. G. Murdock,J. Caro,M. Hermel

DOI: https://doi.org/10.1016/S0015-0282(16)43703-9

IF: 6.7

1978-12-01

Fertility and Sterility

Abstract:
Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides

So Hee Nam,Joonhyuck Park,Heebeom Koo

DOI: https://doi.org/10.1007/s12272-022-01425-y

2023-01-04

Archives of Pharmacal Research

Abstract:Biological cell membranes are a natural barrier for living cells. In the last few decades, the cell membrane has been the main hurdle in the efficient delivery of bioactive and therapeutic agents. To increase the drug efficacy of these agents, additional mediators have been considered. Cell-penetrating peptides (CPPs), a series of oligopeptides composed of mostly hydrophobic and/or positively charged side chains, can increase the interaction with the cell membrane. CPP-based delivery platforms have shown great potential for the efficient and direct cytosol delivery of various cargos, including genes, proteins, and small molecule drugs. Bypassing endocytosis allows the CPP-based delivery systems greater defense against the degradation of protein-based drugs than other drug delivery systems. However, the delivery of CPPs exhibits intrinsically non-specific targeting, which limits their medical applications. To endow CPPs with specific targeting ability, the conjugation of pH-sensitive, enzyme-specific cleavable, and multiple targeting ligands has been reported. Optimization of the length and sequence of CPPs is still needed for various drugs of different sizes and surface charges. Toxicity issues in CPP-based delivery systems should be addressed carefully before clinical use.

pharmacology & pharmacy,chemistry, medicinal
Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review

Sara Silva,António J. Almeida,Nuno Vale,António Almeida

DOI: https://doi.org/10.3390/biom9010022

IF: 6.064

2019-01-10

Biomolecules

Abstract:Cell-penetrating peptides (CPPs), also known as protein translocation domains, membrane translocating sequences or Trojan peptides, are small molecules of 6 to 30 amino acid residues capable of penetrating biological barriers and cellular membranes. Furthermore, CPP have become an alternative strategy to overcome some of the current drug limitations and combat resistant strains since CPPs are capable of delivering different therapeutic molecules against a wide range of diseases. In this review, we address the recent conjugation of CPPs with nanoparticles, which constitutes a new class of delivery vectors with high pharmaceutical potential in a variety of diseases.

biochemistry & molecular biology
The role of cell‐penetrating peptides in potential anti‐cancer therapy

Meiling Zhou,Xi Zou,Kexin Cheng,Suye Zhong,Yangzhou Su,Tao Wu,Yongguang Tao,Li Cong,Bin Yan,Yiqun Jiang

DOI: https://doi.org/10.1002/ctm2.822

IF: 8.554

2022-05-25

Clinical and Translational Medicine

Abstract:CPPs are amino acid sequences that can induce uptake processes by the cells. CPPs can facilitate the intracellular delivery of a variety of anti‐cancer therapeutic moleculars. The mechanisms of the CPPs uptake can be generally categorised into energy‐dependent and direct penetration. The optimisation of CPPs' defects will promote their clinical applications as drug delivery vehicles. Due to the complex physiological structure, microenvironment and multiple physiological barriers, traditional anti‐cancer drugs are severely restricted from reaching the tumour site. Cell‐penetrating peptides (CPPs) are typically made up of 5–30 amino acids, and can be utilised as molecular transporters to facilitate the passage of therapeutic drugs across physiological barriers. Up to now, CPPs have widely been used in many anti‐cancer treatment strategies, serving as an excellent potential choice for oncology treatment. However, their drawbacks, such as the lack of cell specificity, short duration of action, poor stability in vivo, compatibility problems (i.e. immunogenicity), poor therapeutic efficacy and formation of unwanted metabolites, have limited their further application in cancer treatment. The cellular uptake mechanisms of CPPs involve mainly endocytosis and direct penetration, but still remain highly controversial in academia. The CPPs‐based drug delivery strategy could be improved by clever design or chemical modifications to develop the next‐generation CPPs with enhanced cell penetration capability, stability and selectivity. In addition, some recent advances in targeted cell penetration that involve CPPs provide some new ideas to optimise CPPs.

oncology,medicine, research & experimental
Recent CPP-based applications in medicine

Kaido Kurrikoff,Ülo Langel

DOI: https://doi.org/10.1080/17425247.2019.1665021

2019-09-17

Expert Opinion on Drug Delivery

Abstract:Introduction: Cell-penetrating peptides (CPP) offer versatile tools for the field of drug delivery and development of macromolecular therapeutics. These tools have matured into applications that allow the use of proteins, nucleic acid, peptides, imaging agents, and low molecular weight drugs as therapeutic entities.Areas covered: The progress of the field is discussed in the current review, with the examples from a recent couple of years, in the utilization of CPPs in medicine. Specific focus is on the research articles that include applications that have direct translational value. Progress with protein mimicry and its recent leap in medicine is discussed with special attention, but also achievements with nanoformulation and drug targeting is presented.Expert opinion: The opinion section discusses some of the limitations and shortcomings, proposing the areas where more effort should be invested in order to increase the translational value of the current preclinical research.

pharmacology & pharmacy
Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?

B. Lange,A. Levine

1982-09-01

Abstract:
Curb Challenges of the "trojan Horse" Approach: Smart Strategies in Achieving Effective Yet Safe Cell-Penetrating Peptide-Based Drug Delivery.

Yongzhuo Huang,Yifan Jiang,Huiyuan Wang,Jianxin Wang,Meong Cheol Shin,Youngro Byun,Huining He,Yanqin Liang,Victor C Yang

DOI: https://doi.org/10.1016/j.addr.2012.11.007

IF: 16.1

2013-01-01

Advanced Drug Delivery Reviews

Abstract:Cell-penetrating peptide (CPP)-mediated intracellular drug delivery system, often specifically termed as "the Trojan horse approach", has become the "holy grail" in achieving effective delivery of macromolecular compounds such as proteins, DNA, siRNAs, and drug carriers. It is characterized by the unique cell- (or receptor-), temperature-, and payload-independent mechanisms, therefore offering potent means to improve poor cellular uptake of a variety of macromolecular drugs. Nevertheless, this "Trojan horse" approach also acts like a double-edged sword, causing serious safety and toxicity concerns to normal tissues or organs for in vivo application, due to lack of target selectivity of the powerful cell penetrating activity. To overcome this problem of potent yet non-selective penetration vs. targeting delivery, a number of "smart" strategies have been developed in recent years, including controllable CPP-based drug delivery systems based on various stimuli-responsive mechanisms. This review article provides a fundamental understanding of these smart systems, as well as a discussion of their real-time in vivo applicability.
New generation of cell‐penetrating peptides: Functionality and potential clinical application

Siegmund Reissmann,Margarita P. Filatova

DOI: https://doi.org/10.1002/psc.3300

2021-02-21

Journal of Peptide Science

Abstract:Cell‐penetrating peptides (CPPs) can transport various cargoes through membranes of live cells. Since the first generations of CPPs suffered from insufficient cell and tissue selectivity, stability against proteases, and escape from endosomes, a new generation of peptides, with optimized properties, was developed. These are either derived from natural sources or created through the combination of multivalent structures. The second method allows achieving high internalization efficiency, high cell and tissue selectivity, and release from endosomes via hybrid structures, combining sequences for endosomal release, homing sequences, and sequences for activation at the target tissue and for local delivery of cargoes. CPPs with innate tumor selectivity include azurin, crotamine, maurocalcine, lycosin‐I, buffalo cathelicidin, and peptide CB5005. Some of them can penetrate the membranes of live cells and influence intracellular signaling pathways, thereby exerting cytotoxic effects against tumor cells. To obtain multilayer penetration and stabilization against proteolytic degradation, as well as for better handling, CPPs are often conjugated to nanoparticles. A special problem for tumor treatment is the efficiency of drug transport through three‐dimensional cell cultures. Therefore, the capability of CPPs to deliver the drug even to the innermost tissues is of crucial importance. Notably, the ability of certain CPPs to penetrate barriers such as skin, the blood‐brain barrier (BBB), and cornea or conjunctiva of eyes enabled the replacement of dangerous and painful injections with soothing sprays, creams, and drops. However, it is difficult to rank the efficacy of CPPs because transport efficiency and tissue selectivity depend not only on the CPP itself but also on the target tissue or organ, as well as on the cargo and method of CPP‐cargo coupling. Therefore, the present review describes some examples of new‐generation CPPs and aims to provide advice on how to find or create the right CPP for a given task.

biochemistry & molecular biology,chemistry, analytical

Initial clinical experience with a biofragmentable ring for sutureless bowel anastomosis

Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs

Penetrating peptides: Applications in drug delivery

A questionnaire survey of sleep and night-time behaviour in a community-based sample of adults with intellectual disability.

Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.

Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

Lifestyle Modification in Cervical Cancer Survivors: An Ongoing Need

AN APPARATUS FOR MACROSCOPIC CATAPHORESIS EXPERIMENTS

Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application

Cell penetrating peptides: Highlighting points in cancer therapy

Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review

Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics

Cell-Penetrating Peptides: A Powerful Tool for Targeted Drug Delivery

Case report: cystic gynecomastia in a male treated with clomiphene citrate.

Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides

Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review

The role of cell‐penetrating peptides in potential anti‐cancer therapy

Recent CPP-based applications in medicine

Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?

Curb Challenges of the "trojan Horse" Approach: Smart Strategies in Achieving Effective Yet Safe Cell-Penetrating Peptide-Based Drug Delivery.

New generation of cell‐penetrating peptides: Functionality and potential clinical application